Vivopharm Holding ApS — Credit Rating and Financial Key Figures
CVR number: 41452935
Vilvordevej 39 A, 2920 Charlottenlund
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | -6.00 | -6.00 | -7.00 | -7.00 | -7.19 |
| Gross profit | -6.00 | -6.00 | -7.00 | -7.00 | -7.19 |
| EBIT | -6.00 | -6.00 | -7.00 | -7.00 | -7.19 |
| Other financial expenses | -1.00 | -0.91 | |||
| Reduction non-current investment assets | - 100.00 | ||||
| Pre-tax profit | -6.00 | -6.00 | - 107.00 | -8.00 | -8.10 |
| Net earnings | -6.00 | -6.00 | - 107.00 | -8.00 | -8.10 |
Assets (kDKK)
2020 | 2021 | |
|---|---|---|
| Intangible assets total | ||
| Tangible assets total | ||
| Investments total | ||
| Non-current loans receivable | 100.00 | 100.00 |
| Long term receivables total | 100.00 | 100.00 |
| Inventories total | ||
| Short term receivables total | ||
| Balance sheet total (assets) | 100.00 | 100.00 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Share premium account | 60.00 | ||||
| Retained earnings | 54.00 | 47.00 | -59.00 | -67.15 | |
| Profit of the financial year | -6.00 | -6.00 | - 107.00 | -8.00 | -8.10 |
| Shareholders equity total | 94.00 | 88.00 | -20.00 | -27.00 | -35.25 |
| Non-current liabilities total | |||||
| Current trade creditors | 6.00 | 6.00 | 7.00 | 7.00 | 7.30 |
| Other non-interest bearing current liabilities | 6.00 | 13.00 | 20.00 | 27.95 | |
| Current liabilities total | 6.00 | 12.00 | 20.00 | 27.00 | 35.25 |
| Balance sheet total (liabilities) | 100.00 | 100.00 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.